Cbay stock price.

5 days ago · Get CymaBay Therapeutics Inc (CBAY.PH) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Feb 13, 2024 · Detailed statistics for CymaBay Therapeutics, Inc. (CBAY) stock, including valuation metrics, financial numbers, share information and more. ... Stock Price Statistics. The stock price has increased by +301.00% in the last 52 weeks. The beta is 0.28, so CBAY's price volatility has been lower than the market average.CymaBay Therapeutics Inc (CBAY) stock is higher by 0.96% while the S&P 500 is down -0.1% as of 12:11 PM on Tuesday, Jan 9. CBAY is up $0.23 from the previous closing price of $23.56 on volume of 301,844 shares. Over the past year the S&P 500 is higher by 22.27% while CBAY is up 301.86%. CBAY lost -$0.93 per share in the over …CBAY ranks lowest in Stability; there it ranks in the 2nd percentile. CBAY Stock Summary. The capital turnover (annual revenue relative to shareholder's equity) for CBAY is 0.1 -- better than just 13.13% of US stocks. With a price/sales ratio of 84.02, CYMABAY THERAPEUTICS INC has a higher such ratio than 97.51% of stocks in our set.

What happened. Shares of CymaBay Therapeutics ( CBAY 2.92%) were up more than 37% as of 11:15 a.m. ET on Friday. The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced ...The CymaBay Therapeutics 52-week low stock price is 7.26, which is 77.5% below the current share price. The average CymaBay Therapeutics stock price for the last 52 weeks is 14.09. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. CymaBay Therapeutics Inc. is a biopharmaceutical company.

Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...

3 days ago · A. The latest price target for CymaBay Therapeutics ( NASDAQ: CBAY) was reported by LifeSci Capital on Wednesday, February 14, 2024. The analyst firm set a price target for 0.00 expecting CBAY to ... CBAY support price is $23.04 and resistance is $24.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBAY stock will trade within this expected range on the day.CBAY has fallen -$0.10 from the previous closing price of $22.85 on volume of 483,390 shares. Over the past year the S&P 500 has gained 21.52% while CBAY has gained 191.67%. CBAY lost -$0.93 per share the over the last 12 months. Click Here to get the full Stock Report for CymaBay Therapeutics Inc stock.5 days ago · CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today announced that The New England Journal of Medicine (NEJM) has published detailed results from the RESPONSE Phase 3 trial evaluating seladelpar, an investigational …

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you...

Mar 28, 2023 · Shares of CymaBay Therapeutics Inc. (CBAY) have gained 11.4% over the past four weeks to close the last trading session at $8.73, but there could still be a solid upside left in the stock if short ...

CBAY has a higher average analyst price target than 1096.41% of Healthcare stocks. CBAY has a lower variance in analysts' estimates than -2568.4% of stocks in the small market cap category. In the Pharmaceutical Products industry, RMTI , RIGL , and ANIP are the three stocks most similar to CYMABAY THERAPEUTICS INC regarding the price …Based on analysts offering 12 month price targets for CBAY in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .Technical Analysis for CBAY - CymaBay Therapeutics Inc. Quote; Chart; End-of-Day Trading Signals; Intraday Alerts; Profile; Buy or Sell? News; Discussion ...What happened. Shares of CymaBay Therapeutics ( CBAY 2.92%) were up more than 37% as of 11:15 a.m. ET on Friday. The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced ...CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. What this means: CymaBay Therapeutics Inc. (CBAY) gets an Overall Rank of 68, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.

CymaBay Therapeutics Inc (CBAY) Stock Price & News - Google Finance Home CBAY • NASDAQ CymaBay Therapeutics Inc Follow Share $32.18 After Hours: $32.13 (0.15%) -0.048 Closed: Feb 16, 4:54:20 PM... Based on 7 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $28.67 with a high forecast of $36.00 and a low forecast of $20.00. The average price target represents a 20.61% change from the last price of $23.77. Highest Price Target $36.00. Average Price Target $28.67.CymaBay Therapeutics Market Cap: 2.61B, Enterprise value: 762.95M, P/E: -7.31, PEG ratio: -1.54, EPS: -1.09, Revenue: N/A, EBITDA: -74.92M, Income: -106.15M ...Based on analysts projections #CBAY is expected to experience a price decline over the next year. The current average CBAY price target, as estimated by these analysts, is $0.00.. The predictions for the future CBAY stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for CBAY.. It is important to …This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price last Friday.

Aug 18, 2020 · Find the latest CymaBay Therapeutics, Inc. (CBAY) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. ... Nasdaq 15,580.87-49.91 ...CBAY price to book (PB)For valuing companies that are loss-making or have lots of physical asset. Company. 11.17x. Industry. 5.88x. ... Cymabay Therapeutics 's market cap is calculated by multiplying CBAY's current stock price of $32.12 by CBAY's total outstanding shares of 113,403,353.

CBAY is trading at a 1% premium. Price $23.84 Feb 2, 2024 Fair Value $67.78 Feb 2, 2024 Uncertainty Very High 1-Star Price $25.73Research CymaBay Therapeutics' (Nasdaq:CBAY) stock key valuation metrics while comparing it with its industry peers & market side by side. ... The above table shows the analyst CBAY forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current ...CymaBay Therapeutics Market Cap: 2.61B, Enterprise value: 762.95M, P/E: -7.31, PEG ratio: -1.54, EPS: -1.09, Revenue: N/A, EBITDA: -74.92M, Income: -106.15M ...Historical daily share price chart and data for CymaBay Therapeutics since 2014 adjusted for splits and dividends. The latest closing stock price for ...The average twelve-month price prediction for CymaBay Therapeutics is $23.70 with a high price target of $34.00 and a low price target of $12.00. Learn more …Dear cbay community, We are delighted to announce a fantastic new feature that will make your shopping experience with us even more rewarding! 🛍️ Introducing: Bulk discounts! 🎊 Buy more now and you can save more! Our latest feature allows you to get amazing discounts on your favorite products when you buy in bulk. The more you buy, the less you pay!Feb 12, 2024 ... This has Gilead valuing shares of CBAY stock at $32.50 apiece. CBAY Stock - Why is CymaBay (CBAY) Stock Up 25% Today? Source: Sundry Photography ...Aug 2, 2023 · Fintel reports that on August 14, 2023, UBS initiated coverage of Cymabay Therapeutics (NASDAQ:CBAY) with a Buy recommendation.. Analyst Price Forecast Suggests 15.86% Upside. As of August 2, 2023 ...4 days ago · CBAY is trading at a 1% premium. Price $23.84 Feb 2, 2024 Fair Value $67.78 Feb 2, 2024 Uncertainty Very High 1-Star Price $25.73 BETS. Bit Brother Limited Class A Ordinary Shares. $6.63 +0.83 +14.31%. CymaBay Therapeutics Inc. Common Stock (CBAY) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data ...

CBAY - CymaBay Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS) ... CymaBay Therapeutics, Inc. (US:CBAY) has 420 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 132,650,878 shares.

Cymabay Therapeutics (CBAY) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.

Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.Our company focus is to support the scientific, healthcare, and advocacy communities dedicated to improving the standard of care for our patients. Our highly committed employees play a critical role in CymaBay’s success. We live our core values of innovation, teamwork, accountability, integrity, and respect in everything we do. We seek …At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Daniel Menold, Vice President, Finance of CymaBay Therapeutics Inc (NASDAQ:CBAY), has sold 10,000 shares of the company on January 16, 2024, according to a recent SEC Filing. Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock analysis for Cymabay Therapeutics Inc (CBAY:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Ticker Symbol: CBAY: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001042074: CUSIP Number: 23257D103: ISIN Number: US23257D1037Research CymaBay Therapeutics' (Nasdaq:CBAY) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance …The average one-year price target for CymaBay Therapeutics (NasdaqGS:CBAY) has been revised to 31.36 / share. This is an increase of 12.84% from the prior estimate of 27.80 dated January 16, 2024.4 days ago · A high-level overview of CymaBay Therapeutics, Inc. (CBAY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Analyst Price Target for CBAY i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).

CBAY Stock Performance ; Previous close, 23.74 ; Day range, 23.17 - 23.77 ; Year range, 7 - 25 ; Market cap, 2,655,898,000.CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company. Its main business involves the development of therapeutics such as Arhalofenate, MBX-8025, and MBX-2982. These drugs are intended to treat serious metabolic disorders. Arhalofenate is used to treat gout, MBX-2982 is an oral, G-protein coupled receptor agonist being ...Nov 6, 2023 · Over the past 3 months, 14 analysts have published their opinion on CymaBay Therapeutics (NASDAQ:CBAY) stock. These analysts are typically employed by large Wall Street banks and tasked with ...Instagram:https://instagram. canvas pics cheapcar information indiaprice of hotelcheap coaches The 12 analysts offering 1 year price forecasts for CBAY have a max estimate of — and a min estimate of —. Analyst rating Based on 13 analysts giving stock ratings to CBAY in the past 3 months. share price mondelezwe didn't start the fire fall out boy lyrics Feb 17, 2024 · Complete CymaBay Therapeutics Inc. stock information by Barron's. View real-time CBAY stock price and news, along with industry-best analysis. home edward sharpe You can buy or sell CBAY and other ETFs, options, and stocks. View the real-time CBAY price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule at rbnhd ... You are leaving our website! Continue